Improved survival for sequentially as opposed to concurrently delivered neoadjuvant chemotherapy in non-metastatic breast cancer.

about

Improved survival for sequentially as opposed to concurrently delivered neoadjuvant chemotherapy in non-metastatic breast cancer.

Item

http://www.wikidata.org/entity/Q42113569

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Improved survival for sequenti ...... non-metastatic breast cancer.

@en

Improved survival for sequenti ...... non-metastatic breast cancer.

@nl

type

Item

label

Improved survival for sequenti ...... non-metastatic breast cancer.

@en

Improved survival for sequenti ...... non-metastatic breast cancer.

@nl

prefLabel

Improved survival for sequenti ...... non-metastatic breast cancer.

@en

Improved survival for sequenti ...... non-metastatic breast cancer.

@nl

P1476

Improved survival for sequenti ...... non-metastatic breast cancer.

@en

P2093

B E P J Vriens

http://www.w3.org/2001/XMLSchema#string

Breast Cancer Trialists’ Group of the Netherlands (BOOG)

http://www.w3.org/2001/XMLSchema#string

D J van Spronsen

http://www.w3.org/2001/XMLSchema#string

F W P J van den Berkmortel

http://www.w3.org/2001/XMLSchema#string

I J H Vriens

http://www.w3.org/2001/XMLSchema#string

L J C van Warmerdam

http://www.w3.org/2001/XMLSchema#string

M J B Aarts

http://www.w3.org/2001/XMLSchema#string

M de Boer

http://www.w3.org/2001/XMLSchema#string

P G M Peer

http://www.w3.org/2001/XMLSchema#string

S M van Gastel

http://www.w3.org/2001/XMLSchema#string

P2860

A better way for a cancer cell to die

Phase III study of doxorubicin/cyclophosphamide with concomitant versus sequential docetaxel as adjuvant treatment in patients with human epidermal growth factor receptor 2-normal, node-positive breast cancer: BCIRG-005 trial.

Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer.

Scalp cooling for hair preservation and associated characteristics in 1411 chemotherapy patients - results of the Dutch Scalp Cooling Registry.

Protecting against anthracycline-induced myocardial damage: a review of the most promising strategies.

2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours.

Neoadjuvant docetaxel in locally advanced breast cancer.

Dexamethasone enhances programmed cell death 1 (PD-1) expression during T cell activation: an insight into the optimum application of glucocorticoids in anti-cancer therapy

Pathologic complete response predicts recurrence-free survival more effectively by cancer subset: results from the I-SPY 1 TRIAL--CALGB 150007/150012, ACRIN 6657.

Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death.

P2888

s10549-017-4364-8

P31

scholarly article

P356

10.1007/S10549-017-4364-8

http://www.w3.org/2001/XMLSchema#string

P407

English

P577

2017-07-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1090337030

http://www.w3.org/2001/XMLSchema#string

P698

28674765

http://www.w3.org/2001/XMLSchema#string

P932

5602024

http://www.w3.org/2001/XMLSchema#string